Predictors of postoperative morbidity after cytoreduction for advanced ovarian cancer: Analysis and management of complications in upper abdominal surgery
- PMID: 25824857
- DOI: 10.1016/j.ygyno.2015.03.043
Predictors of postoperative morbidity after cytoreduction for advanced ovarian cancer: Analysis and management of complications in upper abdominal surgery
Abstract
Objective: To evaluate the complication rate and its impact in patients who have undergone upper abdominal surgery for treatment of advanced ovarian cancer.
Methods: Patients who have undergone upper abdominal surgery including diaphragm surgery, splenectomy, distal pancreatectomy, gastric resection, liver resection and biliary surgery were considered for the study. Perioperative complications were evaluated and graded according to Clavien-Dindo.
Results: One hundred and twenty one patients were included. Two hundred and twelve surgical procedures were performed. Thirty-six patients reported at least one complication, but 61.1% of these the complication was mild. Median hospital stay for patients with and without complication was 7 vs. 13days respectively (p<0.001). There was a significant correlation between post-operative hospital stay and the total number of surgical procedures (R=0.445, p<0.001). At multivariate analysis, diaphragmatic resection and pancreatic resection were associated with a significant increase of postoperative hospital stay, furthermore diaphragmatic resection (p=0.004), hepatic resection (p=0.004), pancreatectomy (p=0.011) and biliary surgery (p=0.049) were independent predictors of severe (G3-G4) complication.
Conclusions: Rate of complications of patients submitted to upper abdominal surgery for ovarian cancer is acceptable. Prediction of severe complications is the goal for its optimal management. Extensive procedures should be avoided with those patients in which optimal residual tumor could not be reached.
Keywords: Advanced ovarian cancer; Complication rate; Predictors of complication rate; Predictors of postoperative morbidity; Upper abdominal surgery.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
-
The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas.Gynecol Oncol. 2010 Oct;119(1):38-42. doi: 10.1016/j.ygyno.2010.05.031. Epub 2010 Jul 6. Gynecol Oncol. 2010. PMID: 20609464
-
The parameters to estimate postoperative severe complications classified through Clavien-Dindo after upper abdominal surgery in patients with primary and recurrent ovarian cancer.Ginekol Pol. 2019;90(10):557-564. doi: 10.5603/GP.2019.0097. Ginekol Pol. 2019. PMID: 31686411
-
The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.Gynecol Oncol. 2006 Dec;103(3):1083-90. doi: 10.1016/j.ygyno.2006.06.028. Epub 2006 Aug 4. Gynecol Oncol. 2006. PMID: 16890277
-
Management of morbidity associated with pancreatic resection during cytoreductive surgery for epithelial ovarian cancer: A systematic review.Eur J Surg Oncol. 2020 Apr;46(4 Pt A):694-702. doi: 10.1016/j.ejso.2019.11.516. Epub 2019 Nov 29. Eur J Surg Oncol. 2020. PMID: 31806515
-
[Complications of radical surgery for advanced ovarian cancer].Gynecol Obstet Fertil. 2011 Jan;39(1):21-7. doi: 10.1016/j.gyobfe.2010.08.017. Epub 2010 Dec 22. Gynecol Obstet Fertil. 2011. PMID: 21183387 Review. French.
Cited by
-
ASO Author Reflections: Ultra-Radical Resection in Ovarian Cancer: Where Are We and Where Are We Going?Ann Surg Oncol. 2021 Jan;28(1):231-232. doi: 10.1245/s10434-020-08998-2. Epub 2020 Aug 9. Ann Surg Oncol. 2021. PMID: 32776187 No abstract available.
-
Validation of a risk-based algorithm to reduce poor operative outcomes after complex surgery for ovarian cancer.Int J Gynecol Cancer. 2023 Jan 3;33(1):83-88. doi: 10.1136/ijgc-2022-003799. Int J Gynecol Cancer. 2023. PMID: 36517075 Free PMC article.
-
Factors Predicting 30-Day Grade IIIa-V Clavien-Dindo Classification Complications and Delayed Chemotherapy Initiation after Cytoreductive Surgery for Advanced-Stage Ovarian Cancer: A Prospective Cohort Study.Cancers (Basel). 2022 Aug 29;14(17):4181. doi: 10.3390/cancers14174181. Cancers (Basel). 2022. PMID: 36077721 Free PMC article.
-
Reflections on the role of diaphragmatic resection techniques in cytoreductive surgery: indications, outcomes, and unresolved questions.Langenbecks Arch Surg. 2025 Mar 22;410(1):102. doi: 10.1007/s00423-025-03646-3. Langenbecks Arch Surg. 2025. PMID: 40119959 Free PMC article. No abstract available.
-
Diaphragmatic stripping versus full-thickness diaphragmatic resection in cytoreductive surgery: a meta-analysis of the current evidence.Langenbecks Arch Surg. 2025 Jan 25;410(1):50. doi: 10.1007/s00423-025-03611-0. Langenbecks Arch Surg. 2025. PMID: 39862326 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical